| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5577864 | Cor et Vasa | 2017 | 6 Pages |
Abstract
The use of modern guidelines-recommended treatment (DES or novel antiplatelet agents) is surprisingly poor and is not limited by economic restrictions but rather by lack of guidelines knowledge or lack of physicians' activity to quickly implement the new guidelines.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Petr Widimsky, Petr TouÅ¡ek, FrantiÅ¡ek TouÅ¡ek, Martin Sluka, Alexandra Vodzinská, Petra Kupková, Martin Hutyra, Jiri Jarkovsky, on behalf of the CZECH-3 and ATHRO-II investigators on behalf of the CZECH-3 and ATHRO-II investigators,